Talk to us early and often, but deals take time, says Roche’s Sabry

One of the top mistakes that biotechs make when seeking deals with pharma companies is not building relations along the way, and only approaching when they’re ready and expecting to enter a deal, said James Sabry on The BioCentury Show.

Sabry, global head of pharma partnering at Roche (SIX:ROG; OTCQX:RHHBY), said companies frequently make the error of “not coming and talking to us until right at the end, right when they want to do the deal.” Instead, they should realize there’s a series of meetings involved for the pharma to get to know potential partners. ...